Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter came in at $500.1 million versus the consensus estimate of $470.53 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.